Hanson & Doremus Investment Management has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing reports that the firm manages a total of 493 distinct equity positions.
The top holdings in the portfolio include Apple Inc., which is held in 16,314 shares, and AbbVie Inc. with 4,069 shares. Other significant positions include Amgen Incorporated (4,602 shares), Eli Lilly & Co. (3,901 shares), and Chevron Corp. (1,223 shares). The filing also lists a substantial number of exchange-traded funds, including the iShares Gold ETF, iShares Core Dividend Growth ETF, and various iShares ESG-themed ETFs.
The report details the voting rights for these holdings, indicating that all shares listed in the information table are held with sole voting and dispositive power.
